208 related articles for article (PubMed ID: 22399516)
21. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
[TBL] [Abstract][Full Text] [Related]
22. Lipoprotein-associated phospholipase A
Garg PK; Norby FL; Polfus LM; Boerwinkle E; Gibbs RA; Grove ML; Folsom AR; Garimella PS; Matsushita K; Hoogeveen RC; Ballantyne CM
Atherosclerosis; 2018 Jan; 268():12-18. PubMed ID: 29169030
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of lipoprotein-associated phospholipase A
Han L; Zhong C; Bu X; Xu T; Wang A; Peng Y; Xu T; Wang J; Peng H; Li Q; Ju Z; Geng D; Zhang Y; He J;
Atherosclerosis; 2017 Nov; 266():1-7. PubMed ID: 28934604
[TBL] [Abstract][Full Text] [Related]
24. Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study.
Daniels LB; Laughlin GA; Sarno MJ; Bettencourt R; Wolfert RL; Barrett-Connor E
J Am Coll Cardiol; 2008 Mar; 51(9):913-9. PubMed ID: 18308160
[TBL] [Abstract][Full Text] [Related]
25. Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease.
Hatoum IJ; Nelson JJ; Cook NR; Hu FB; Rimm EB
Am J Clin Nutr; 2010 Mar; 91(3):786-93. PubMed ID: 20107195
[TBL] [Abstract][Full Text] [Related]
26. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
Corson MA; Jones PH; Davidson MH
Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
[TBL] [Abstract][Full Text] [Related]
27. Lipoprotein associated phospholipase A2 activity & its correlation with oxidized LDL & glycaemic status in early stages of type-2 diabetes mellitus.
Garg S; Madhu SV; Suneja S
Indian J Med Res; 2015 Jan; 141(1):107-14. PubMed ID: 25857502
[TBL] [Abstract][Full Text] [Related]
28. The association between uncarboxylated matrix Gla protein and lipoprotein-associated phospholipase A2.
Mayer O; Seidlerová J; Vaněk J; Kielbergerová L; Bruthans J; Filipovský J; Wohlfahrt P; Cífková R; Trefil L; Knapen MH; Drummen NE; Vermeer C
Maturitas; 2015 Jan; 80(1):82-8. PubMed ID: 25458708
[TBL] [Abstract][Full Text] [Related]
29. Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress.
Koenig W; Twardella D; Brenner H; Rothenbacher D
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1586-93. PubMed ID: 16627803
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of Lipoprotein-Associated Phospholipase A
Tibuakuu M; Kianoush S; DeFilippis AP; McEvoy JW; Zhao D; Guallar E; Ballantyne CM; Hoogeveen RC; Blaha MJ; Michos ED
Am J Cardiol; 2018 May; 121(9):1056-1064. PubMed ID: 29525060
[TBL] [Abstract][Full Text] [Related]
31. The epidemiology of Lp-PLA(2): distribution and correlation with cardiovascular risk factors in a population-based cohort.
Persson M; Nilsson JA; Nelson JJ; Hedblad B; Berglund G
Atherosclerosis; 2007 Feb; 190(2):388-96. PubMed ID: 16530769
[TBL] [Abstract][Full Text] [Related]
32. Lipoprotein-associated phospholipase A
Garg PK; Jorgensen NW; McClelland RL; Jenny NS; Criqui MH; Allison MA; Greenland P; Rosenson RS; Siscovick DS; Cushman M
Vasc Med; 2017 Feb; 22(1):5-12. PubMed ID: 28215109
[TBL] [Abstract][Full Text] [Related]
33. Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment.
Iwase M; Sonoki K; Sasaki N; Ohdo S; Higuchi S; Hattori H; Iida M
Atherosclerosis; 2008 Feb; 196(2):931-6. PubMed ID: 17350631
[TBL] [Abstract][Full Text] [Related]
34. Association of lipoprotein-associated phospholipase A₂ activity with components of the metabolic syndrome in apparently healthy boys.
Hirschler V; Meroño T; Maccallini G; Gomez Rosso L; Aranda C; Brites F
Cardiovasc Hematol Agents Med Chem; 2011 Apr; 9(2):78-83. PubMed ID: 21476960
[TBL] [Abstract][Full Text] [Related]
35. [Lipoprotein-associated phospholipase A2 serum levels in patients from different categories of cardiovascular risk].
Nozadze DN; Sergienko IV; Balakhonova TV; Semenova AE; Vlasik TN; Kukharchuk VV
Kardiologiia; 2014; 54(3):57-63. PubMed ID: 25102750
[TBL] [Abstract][Full Text] [Related]
36. The role of lipoprotein-associated phospholipase A(2) in the metabolic syndrome and diabetes.
Noto H; Chitkara P; Raskin P
J Diabetes Complications; 2006; 20(6):343-8. PubMed ID: 17070436
[TBL] [Abstract][Full Text] [Related]
37. Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity.
Constantinides A; de Vries R; van Leeuwen JJ; Gautier T; van Pelt LJ; Tselepis AD; Lagrost L; Dullaart RP
Eur J Intern Med; 2012 Oct; 23(7):633-8. PubMed ID: 22902096
[TBL] [Abstract][Full Text] [Related]
38. Lp-PLA2 activity and mass are associated with increased incidence of ischemic stroke: a population-based cohort study from Malmö, Sweden.
Persson M; Berglund G; Nelson JJ; Hedblad B
Atherosclerosis; 2008 Sep; 200(1):191-8. PubMed ID: 18201705
[TBL] [Abstract][Full Text] [Related]
39. Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke.
Elkind MS; Tai W; Coates K; Paik MC; Sacco RL
Cerebrovasc Dis; 2009; 27(1):42-50. PubMed ID: 19018137
[TBL] [Abstract][Full Text] [Related]
40. [Impact of gender on lipoprotein-associated phospholipase A2 activity and association with known cardiovascularrisk factors].
Jia ZR; Zhao D; Qi Y; Wang W; Wang M; Sun JY; Qin LP; Liu J
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Nov; 41(11):962-7. PubMed ID: 24370228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
